Integrating genomics into clinical pediatric oncology using the molecular tumor board at MSKCC.
Projects
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.
Read More
Childhood cancer mutagenesis caused by transposase-derived PGBD5
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy
PGBD5 promotes site-specific oncogenic mutations in human tumors
